As of March 2025 Amphastar Pharmaceuticals has a market cap of NZ$2.35 Billion. This makes Amphastar Pharmaceuticals the world's 4968th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | NZ$2.35 B | -27.06% |
2024 | NZ$3.22 B | -31.22% |
2023 | NZ$4.68 B | 119.66% |
2022 | NZ$2.13 B | 30.74% |
2021 | NZ$1.63 B | 23.25% |
2020 | NZ$1.32 B | -0.77% |
2019 | NZ$1.33 B | -3.57% |
2018 | NZ$1.38 B | 11.07% |
2017 | NZ$1.24 B | 1.77% |
2016 | NZ$1.22 B | 30.23% |
2015 | NZ$0.93 B | 42.05% |
2014 | NZ$0.66 B |
On Mar 22nd, 2025 the market cap of Amphastar Pharmaceuticals was reported to be: